These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 30806304)

  • 1. Brain-on-a-chip Devices for Drug Screening and Disease Modeling Applications.
    Miccoli B; Braeken D; Li YE
    Curr Pharm Des; 2018; 24(45):5419-5436. PubMed ID: 30806304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lab-on-a-Chip Platforms as Tools for Drug Screening in Neuropathologies Associated with Blood-Brain Barrier Alterations.
    Staicu CE; Jipa F; Axente E; Radu M; Radu BM; Sima F
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34205550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung-on-a-chip: the future of respiratory disease models and pharmacological studies.
    Shrestha J; Razavi Bazaz S; Aboulkheyr Es H; Yaghobian Azari D; Thierry B; Ebrahimi Warkiani M; Ghadiri M
    Crit Rev Biotechnol; 2020 Mar; 40(2):213-230. PubMed ID: 31906727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Strategies and Future Perspectives of Skin-on-a-Chip Platforms: Innovations, Technical Challenges and Commercial Outlook.
    Bal-Öztürk A; Miccoli B; Avci-Adali M; Mogtader F; Sharifi F; Çeçen B; Yaşayan G; Braeken D; Alarcin E
    Curr Pharm Des; 2018; 24(45):5437-5457. PubMed ID: 30727878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lab-On-A-Chip for the Development of Pro-/Anti-Angiogenic Nanomedicines to Treat Brain Diseases.
    Subramaniyan Parimalam S; Badilescu S; Sonenberg N; Bhat R; Packirisamy M
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Microfluidic Models for Neurodegenerative Disorders.
    Osaki T; Shin Y; Sivathanu V; Campisi M; Kamm RD
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 28881425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Microfluidic Blood-Brain Barrier (BBB) Models.
    Oddo A; Peng B; Tong Z; Wei Y; Tong WY; Thissen H; Voelcker NH
    Trends Biotechnol; 2019 Dec; 37(12):1295-1314. PubMed ID: 31130308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Brain-Pathophysiology-Mimetic Platforms for Studying Neurodegenerative Diseases: Brain Organoids and Brains-on-a-Chip.
    Bang S; Lee S; Choi N; Kim HN
    Adv Healthc Mater; 2021 Jun; 10(12):e2002119. PubMed ID: 34028201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cultivating human tissues and organs over lab-on-a-chip models: Recent progress and applications.
    Bhagat S; Singh S
    Prog Mol Biol Transl Sci; 2022; 187(1):205-240. PubMed ID: 35094775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microfluidic organ-on-a-chip models of human liver tissue.
    Moradi E; Jalili-Firoozinezhad S; Solati-Hashjin M
    Acta Biomater; 2020 Oct; 116():67-83. PubMed ID: 32890749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-on-a-chip platforms and biosensor integration for disease modeling and phenotypic drug screening.
    Criscione J; Rezaei Z; Hernandez Cantu CM; Murphy S; Shin SR; Kim DH
    Biosens Bioelectron; 2023 Jan; 220():114840. PubMed ID: 36402101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-on-a-chip for Drug Screening.
    Lee IC
    Curr Pharm Des; 2018; 24(45):5407-5418. PubMed ID: 30727877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.
    Ahadian S; Civitarese R; Bannerman D; Mohammadi MH; Lu R; Wang E; Davenport-Huyer L; Lai B; Zhang B; Zhao Y; Mandla S; Korolj A; Radisic M
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29034591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart-on-Chip for Combined Cellular Dynamics Measurements and Computational Modeling Towards Clinical Applications.
    Park J; Wu Z; Steiner PR; Zhu B; Zhang JXJ
    Ann Biomed Eng; 2022 Feb; 50(2):111-137. PubMed ID: 35039976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlling Differentiation of Stem Cells for Developing Personalized Organ-on-Chip Platforms.
    Geraili A; Jafari P; Hassani MS; Araghi BH; Mohammadi MH; Ghafari AM; Tamrin SH; Modarres HP; Kolahchi AR; Ahadian S; Sanati-Nezhad A
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 28910516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microengineered Organ-on-a-chip Platforms towards Personalized Medicine.
    Kankala RK; Wang SB; Chen AZ
    Curr Pharm Des; 2018; 24(45):5354-5366. PubMed ID: 30799783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosensors Integration in Blood-Brain Barrier-on-a-Chip: Emerging Platform for Monitoring Neurodegenerative Diseases.
    Mir M; Palma-Florez S; Lagunas A; López-Martínez MJ; Samitier J
    ACS Sens; 2022 May; 7(5):1237-1247. PubMed ID: 35559649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung on a Chip for Drug Screening and Design.
    Kızılkurtlu AA; Polat T; Aydın GB; Akpek A
    Curr Pharm Des; 2018; 24(45):5386-5396. PubMed ID: 30734673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organ-on-chip models: Implications in drug discovery and clinical applications.
    Mittal R; Woo FW; Castro CS; Cohen MA; Karanxha J; Mittal J; Chhibber T; Jhaveri VM
    J Cell Physiol; 2019 Jun; 234(6):8352-8380. PubMed ID: 30443904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.